AZTA FINANCIAL STATEMENTS

Azenta Inc — balance sheet, income statement and cash flow trends

AZTAAzenta Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue596.6 M $+1.8%

Gross Profit265.8 M $-1.1%

Operating Income-15.6 M $—

EBITDA-92.9 M $-272.5%

Net Income-178.2 M $—

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
AZTA	1.8%	44.6%	-15.6%	-29.9%
ANN	11.4%	41.9%	15.2%	6.7%
FPH	4.8%	64.2%	34.9%	20.0%
CTEC	6.8%	55.8%	25.3%	7.2%
RMD	10.5%	61.2%	39.1%	27.4%
Industry median	6.4%	53.7%	13.8%	3.9%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
AZTA	1.8%	44.6%	-15.6%	-29.9%
BLFS	40.9%	63.9%	-7.5%	-10.5%
STAA	4.0%	76.4%	-1.4%	-7.2%
ATRC	15.0%	75.5%	4.5%	-0.8%
PLSE	-69.9%	-91.1%	-9,866.7%	-9,929.0%
XRAY	-1.0%	48.9%	-3.5%	-17.1%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity1.6 B $82%
Current Liabilities257.2 M $14%
Long-term Liabilities92 M $5%

Key Figures

YoY change

Total Assets1.9 B $-6.8%

Total Liabilities349.2 M $+2.6%

Total Equity1.6 B $-8.6%

Cash & ST Investments380.5 M $+15.9%

Total Debt55.7 M $+3.8%

Net Debt-178.3 M $—

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
AZTA	2.83	3.6%	3.50	81.7%
ANN	2.36	46.2%	2.10	59.3%
FPH	2.31	6.9%	-0.39	74.1%
CTEC	1.53	100.0%	2.33	40.1%
RMD	3.01	13.0%	-0.38	73.9%
Industry median	2.40	34.8%	1.44	62.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
AZTA	2.83	3.6%	3.50	81.7%
BLFS	7.30	4.0%	8.87	92.8%
STAA	5.12	10.6%	30.83	78.1%
ATRC	4.29	15.2%	-2.88	76.4%
PLSE	7.26	10.8%	0.83	81.2%
XRAY	1.53	176.9%	-16.86	25.2%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow61 M $-9.9%

Capital Expenditures32.3 M $-9.5%

Free Cash Flow28.7 M $-10.3%

Dividends Paid——

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
AZTA	10.2%	4.8%	5.4%	-34.2%
ANN	11.7%	8.3%	3.4%	173.5%
FPH	28.4%	21.0%	7.4%	141.7%
CTEC	19.1%	14.1%	4.9%	265.8%
RMD	34.2%	31.7%	2.5%	124.8%
Industry median	13.8%	8.6%	3.8%	128.3%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
AZTA	10.2%	4.8%	5.4%	-34.2%
BLFS	17.9%	-1.8%	19.7%	-170.5%
STAA	-17.3%	-18.9%	1.7%	238.7%
ATRC	11.7%	9.7%	3.2%	-1,401.3%
PLSE	-7,349.7%	-7,390.0%	40.3%	74.0%
XRAY	7.3%	2.8%	4.5%	-42.7%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AZTA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.